You are here:
Two key factors set us apart from other actors in global health:
In this section, we explain Gavi’s partnership model and explain the role of each of the Vaccine Alliance’s members.
The Bill & Melinda Gates Foundation's initial pledge of US$ 750 million in 1999 provided the seed money to launch Gavi.
As a founding member of Gavi and the UN's specialist agency on global health issues, WHO is a key Vaccine Alliance partner.
As the world's biggest buyer and supplier of vaccines for developing countries, UNICEF has a pivotal role in the Vaccine Alliance.
The World Bank brings the expertise of the world's biggest source of development assistance to the Vaccine Alliance.
Developing countries are the most important part of the Vaccine Alliance. They apply for support, manage grants and finance immunisation programmes.
Industrialised country governments' experience and funding ensure health is prioritised in development programmes.
CSOs help deliver vaccines to remote communities, implement vaccine programmes and advocate for immunisation.
More than half of Gavi vaccine suppliers are based in emerging markets.
Gavi harnesses the technical expertise of the IFPMA to ensure new vaccines are available that address the needs of developing countries.
Partnering with the research community allows Gavi to tap in the latest information and thinking from the scientific, medical and product delivery communities.
Gavi's partnership model
Close to 580 million
Since 2000, Gavi support has contributed to the immunisation of close to 580 million children.
16 September 2016
Saving Antibiotics So That Antibiotics Can Save Lives
Wall Street Journal
03 March 2015
Ebola vaccine research in Africa
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2016
modal window here